Review



deidentified clinformatics data mart database cdm  (Optum Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Optum Inc deidentified clinformatics data mart database cdm
    Deidentified Clinformatics Data Mart Database Cdm, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+data+mart+database+%5Bclinformatics%5D/clinformatics+data+database+mart/pmc13157083-146-10-9
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database cdm - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations.
    Article Snippet: METHODS Study design and participants This was a retrospective cohort study of US patients hospitalised with a viral LRTD from 1 January 2015 to 31 March 2023 using Optum’s deidentified Clinformatics Data Mart Database (Optum CDM).

    Article Title: Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations.
    Article Snippet: Ethics approval All data in Optum’s deidentified Clinformatics Data Mart Database are Health Insurance Portability and Accountability Act (1996) compliant and deidentified to adhere with all relevant US regulations and privacy laws.

    Article Title: Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations.
    Article Snippet: All data in Optum’s deidentified Clinformatics Data Mart Database are Health Insurance Portability and Accountability Act (1996) compliant and B M J O pen R espiratory R esearch: first published as 10.1136/bm jresp-2025-003552 on 18 June 2026.

    Article Title: Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations.
    Article Snippet: Methods In this retrospective analysis, adults hospitalised between 1 January 2015 and 31 March 2023 were identified using Optum’s deidentified Clinformatics Data Mart Database.

    Article Title: Psychosocial factors, guideline-directed medical therapy, and healthcare resource use among patients newly diagnosed with heart failure in the United States
    Article Snippet: This study was conducted using claims data from the Optum's deidentified Clinformatics® Data Mart Database (CDM) between January 1, 2016 and March 31, 2023.

    Article Title: Economic burden associated with switching from frontline pegaspargase or calaspargase pegol to second-line recombinant Erwinia in pediatrics and adolescents/young adults with acute lymphoblastic leukemia.
    Article Snippet: Materials and methods: This was a retrospective study using Optum’s deidentified Clinformatics Data Mart database.



    Similar Products

    86
    Optum Inc deidentified clinformatics data mart database cdm
    Deidentified Clinformatics Data Mart Database Cdm, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+data+mart+database+%5Bclinformatics%5D/clinformatics+data+database+mart/pmc13157083-146-10-9
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database cdm - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Optum Inc deidentified clinformatics data mart database
    Deidentified Clinformatics Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+data+mart+database+%5Bclinformatics%5D/clinformatics+data+database+mart/pm41920013-2-3-2
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Optum Inc deidentified clinformatics data mart database datasets
    Study design. * The index date for the 1-dose and 2-dose cohorts was the date of receipt of the first and second RZV dose, respectively. The index date for unvaccinated patients corresponded to that of the vaccinated patients. Note: Propensity score matching was done at the index date. For each AID condition and sensitivity analyses, separate propensity scores and different sets of potential confounders were included. For stratified analysis with matched variables, individuals were matched on AID condition, age group, and medication category; then 1:3 matched on propensity scores with the list of covariates. Abbreviations: AID, autoimmune disease; CDM, Optum <t>Clinformatics®</t> Data Mart Database; HZ, herpes zoster; IR, incidence rate; non-RZV cohort, unvaccinated patients; RZV, adjuvanted recombinant zoster vaccine; RZV cohort, RZV-vaccinated patients; US, United States; VE, vaccine effectiveness; ZVL, live-attenuated varicella-zoster virus vaccine.
    Deidentified Clinformatics Data Mart Database Datasets, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+data+mart+database+%5Bclinformatics%5D/clinformatics+data+database+mart/pmc12718021-18-9-8
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database datasets - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    Study design. * The index date for the 1-dose and 2-dose cohorts was the date of receipt of the first and second RZV dose, respectively. The index date for unvaccinated patients corresponded to that of the vaccinated patients. Note: Propensity score matching was done at the index date. For each AID condition and sensitivity analyses, separate propensity scores and different sets of potential confounders were included. For stratified analysis with matched variables, individuals were matched on AID condition, age group, and medication category; then 1:3 matched on propensity scores with the list of covariates. Abbreviations: AID, autoimmune disease; CDM, Optum Clinformatics® Data Mart Database; HZ, herpes zoster; IR, incidence rate; non-RZV cohort, unvaccinated patients; RZV, adjuvanted recombinant zoster vaccine; RZV cohort, RZV-vaccinated patients; US, United States; VE, vaccine effectiveness; ZVL, live-attenuated varicella-zoster virus vaccine.

    Journal: The Journal of Infectious Diseases

    Article Title: Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases

    doi: 10.1093/infdis/jiaf395

    Figure Lengend Snippet: Study design. * The index date for the 1-dose and 2-dose cohorts was the date of receipt of the first and second RZV dose, respectively. The index date for unvaccinated patients corresponded to that of the vaccinated patients. Note: Propensity score matching was done at the index date. For each AID condition and sensitivity analyses, separate propensity scores and different sets of potential confounders were included. For stratified analysis with matched variables, individuals were matched on AID condition, age group, and medication category; then 1:3 matched on propensity scores with the list of covariates. Abbreviations: AID, autoimmune disease; CDM, Optum Clinformatics® Data Mart Database; HZ, herpes zoster; IR, incidence rate; non-RZV cohort, unvaccinated patients; RZV, adjuvanted recombinant zoster vaccine; RZV cohort, RZV-vaccinated patients; US, United States; VE, vaccine effectiveness; ZVL, live-attenuated varicella-zoster virus vaccine.

    Article Snippet: We conducted a retrospective matched cohort study using Optum's deidentified Clinformatics® Data Mart Database datasets from January 2018 to December 2021.

    Techniques: Recombinant, Virus